Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Serous Adenocarcinoma”

355 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 355 results

Large-scale testing (Phase 3)Active Not RecruitingNCT02446600
What this trial is testing

Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Transitional Cell CarcinomaFallopian Tube Undifferentiated Carcinoma+10 more
National Cancer Institute (NCI) 579
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Large-scale testing (Phase 3)Study completedNCT00002568
What this trial is testing

Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Gynecologic Oncology Group 470
Testing effectiveness (Phase 2)Ended earlyNCT00331422
What this trial is testing

Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Study completedNCT03108131
What this trial is testing

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Who this might be right for
Skin Squamous Cell CarcinomaAppendix AdenocarcinomaRare Lesion+9 more
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT05870761
What this trial is testing

Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma

Who this might be right for
Recurrent Endometrial Serous Adenocarcinoma
Casey Cosgrove 8
Not applicableStudy completedNCT06978595
What this trial is testing

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies

Who this might be right for
Colorectal CarcinomaCancerSignet Ring Adenocarcinoma of the Colon
asmaa salama ibrahim 8,171
Testing effectiveness (Phase 2)Looking for participantsNCT04716686
What this trial is testing

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Who this might be right for
Endometrial CarcinomaSerous Carcinoma
Shandong University 83
Early research (Phase 1)Study completedNCT02179970
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers

Who this might be right for
Pancreatic Adenocarcinoma MetastaticOvarian Serous AdenocarcinomaColorectal Cancer Metastatic
CCTU- Cancer Theme 26
Not applicableLooking for participantsNCT02073500
What this trial is testing

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

Who this might be right for
Pseudomyxoma PeritoneiColorectal CarcinomaOvarian Carcinoma+1 more
Oslo University Hospital 300
Testing effectiveness (Phase 2)WithdrawnNCT04030000
What this trial is testing

Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation

Who this might be right for
Uterine Carcinoma
Northwell Health
Testing effectiveness (Phase 2)Looking for participantsNCT07629609
What this trial is testing

BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

Who this might be right for
Pancreatic Cancer, AdultGastroesophageal Cancer (GC)
Barbara Malene Fischer 90
Testing effectiveness (Phase 2)Study completedNCT00059787
What this trial is testing

Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma

Who this might be right for
Brenner TumorFallopian Tube CancerOvarian Clear Cell Cystadenocarcinoma+6 more
National Cancer Institute (NCI) 56
Large-scale testing (Phase 3)Active Not RecruitingNCT01167712
What this trial is testing

Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous AdenocarcinomaFallopian Tube Transitional Cell Carcinoma+27 more
National Cancer Institute (NCI) 692
Testing effectiveness (Phase 2)Ended earlyNCT00447226
What this trial is testing

Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy Exists

Who this might be right for
Cancer
GlaxoSmithKline 32
Not applicableWithdrawnNCT00053235
What this trial is testing

Research Study in Patients With Advanced Ovarian Epithelial Cancer

Who this might be right for
Ovarian Serous CystadenocarcinomaOvarian Serous Surface Papillary AdenocarcinomaStage IIIA Ovarian Cancer+3 more
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00506779
What this trial is testing

Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma

Who this might be right for
Uterine Cancer
M.D. Anderson Cancer Center 17
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Study completedNCT04080284
What this trial is testing

Trial of Maintenance With Niraparib- Uterine Serous Carcinoma

Who this might be right for
Endometrial CancerPapillary Serous Endometrial CarcinomaUterine Serous Carcinoma+2 more
Northwell Health 22
Early research (Phase 1)Study completedNCT01489371
What this trial is testing

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
Gynecologic Oncology Group 16
Next Page